2023
An AI-powered patient triage platform for future viral outbreaks using COVID-19 as a disease model
Charkoftaki G, Aalizadeh R, Santos-Neto A, Tan W, Davidson E, Nikolopoulou V, Wang Y, Thompson B, Furnary T, Chen Y, Wunder E, Coppi A, Schulz W, Iwasaki A, Pierce R, Cruz C, Desir G, Kaminski N, Farhadian S, Veselkov K, Datta R, Campbell M, Thomaidis N, Ko A, Thompson D, Vasiliou V. An AI-powered patient triage platform for future viral outbreaks using COVID-19 as a disease model. Human Genomics 2023, 17: 80. PMID: 37641126, PMCID: PMC10463861, DOI: 10.1186/s40246-023-00521-4.Peer-Reviewed Original ResearchConceptsCOVID-19 patientsDisease severityViral outbreaksFuture viral outbreaksLength of hospitalizationIntensive care unitWorse disease prognosisLife-threatening illnessEffective medical interventionsCOVID-19Clinical decision treeGlucuronic acid metabolitesNew potential biomarkersHospitalization lengthCare unitComorbidity dataSerotonin levelsDisease progressionHealthy controlsPatient outcomesDisease prognosisPatient transferPatientsHealthcare resourcesPotential biomarkersAntimicrobial resistance in Escherichia coli and Klebsiella pneumoniae urine isolates from a national sample of home-based primary care patients with dementia
Datta R, Pirruccio G, Fried T, O’Leary J, Zullo A, Cohen A. Antimicrobial resistance in Escherichia coli and Klebsiella pneumoniae urine isolates from a national sample of home-based primary care patients with dementia. Infection Control And Hospital Epidemiology 2023, 44: 1873-1876. PMID: 37211919, PMCID: PMC10663380, DOI: 10.1017/ice.2023.98.Peer-Reviewed Original ResearchAntibiotic therapy is associated with adverse drug events among older adults with advanced cancer: A cohort study
Datta R, Han L, Doyle M, Allore H, Sanft T, Quagliarello V, Juthani-Mehta M. Antibiotic therapy is associated with adverse drug events among older adults with advanced cancer: A cohort study. Palliative Medicine 2023, 37: 793-798. PMID: 36999898, DOI: 10.1177/02692163231162889.Peer-Reviewed Original ResearchConceptsAdverse drug eventsAntibiotic therapyDrug eventsAdvanced cancerOlder adultsIndex admissionPalliative chemotherapyCohort studyTertiary care centerHospitalized older adultsPalliative care providersMultidrug-resistant organismsMean ageCommon tumorsCare centerCare providersRatio of daysSolid tumorsMultivariable testingPatientsTherapyStandardized criteriaCancerMean timeAdultsNonutility of procalcitonin for diagnosing bacterial pneumonia in patients with severe COVID-19
Cohen A, Glick L, Lee S, Kunitomo Y, Tsang D, Pitafi S, Toro P, Ristic N, Zhang E, Carey G, Datta R, Dela Cruz C, Gautam S. Nonutility of procalcitonin for diagnosing bacterial pneumonia in patients with severe COVID-19. European Clinical Respiratory Journal 2023, 10: 2174640. PMID: 36815942, PMCID: PMC9930745, DOI: 10.1080/20018525.2023.2174640.Peer-Reviewed Original ResearchSevere COVID-19Bacterial superinfectionBacterial pneumoniaCOVID-19Lower respiratory culturesSuperimposed bacterial pneumoniaUtility of procalcitoninProcalcitonin measurementImmune biomarkersClinical resemblanceRespiratory culturesImmunomodulatory agentsProcalcitoninPatientsBacterial infectionsSuperinfectionCurve analysisSignificant riskCharacteristic curvePneumoniaTime of cultureDiagnosisInfectionBiomarkers
2022
Prevalence and treatment of postobstructive pneumonia among older adults with advanced cancer
Lee S, O’Donovan L, Cohen A, Gautam S, Quagliarello V, Juthani-Mehta M, Datta R. Prevalence and treatment of postobstructive pneumonia among older adults with advanced cancer. Antimicrobial Stewardship & Healthcare Epidemiology 2022, 2: e152. PMID: 36483405, PMCID: PMC9726473, DOI: 10.1017/ash.2022.293.Peer-Reviewed Original ResearchClinical outcomes following dalbavancin administration in patients with barriers to outpatient parenteral antimicrobial therapy
Tuan J, Kayani J, Fisher A, Kotansky B, Dembry L, Datta R. Clinical outcomes following dalbavancin administration in patients with barriers to outpatient parenteral antimicrobial therapy. Antimicrobial Stewardship & Healthcare Epidemiology 2022, 2: e83. PMID: 36483361, PMCID: PMC9726471, DOI: 10.1017/ash.2022.229.Peer-Reviewed Original ResearchDalbavancin administrationOutpatient parenteral antimicrobial therapyDose of dalbavancinMedian antibiotic durationSoft tissue infectionsParenteral antimicrobial therapyAntibiotic durationDeveloped hepatotoxicityClinical cureSeptic arthritisClinical outcomesAntimicrobial therapyPatientsAdministrationDaysEndocarditisArthritisBacteremiaOsteomyelitisHepatotoxicityTherapyDalbavancinInfectionDose
2021
Surveillance of adverse drug events associated with tocilizumab in hospitalized veterans with coronavirus disease 2019 (COVID-19) to inform patient safety and pandemic preparedness
Datta R, Barrett A, Burk M, Salone C, Au A, Cunningham F, Fisher A, Dembry LM, Akgün KM. Surveillance of adverse drug events associated with tocilizumab in hospitalized veterans with coronavirus disease 2019 (COVID-19) to inform patient safety and pandemic preparedness. Infection Control And Hospital Epidemiology 2021, 43: 1488-1491. PMID: 33985598, PMCID: PMC8160489, DOI: 10.1017/ice.2021.227.Peer-Reviewed Original Research
2020
Education needed to improve antimicrobial use during end-of-life care of older adults with advanced cancer: A cross-sectional survey
Datta R, Topal J, McManus D, Sanft T, Dembry LM, Morrison LJ, Quagliarello V, Juthani-Mehta M. Education needed to improve antimicrobial use during end-of-life care of older adults with advanced cancer: A cross-sectional survey. Palliative Medicine 2020, 35: 236-241. PMID: 32928066, DOI: 10.1177/0269216320956811.Peer-Reviewed Original ResearchConceptsEscalation of careAdvance care planningLife careAdvanced cancerCross-sectional surveyIntravenous antimicrobialsOlder adultsAntimicrobial useCare planningSingle-center cross-sectional surveyEducational interventionAdvance care plansRole of antimicrobialsClinical deteriorationPercent of respondentsAdverse eventsOral antimicrobialsMedicine subspecialistsCare plansInpatient medicineCareCancerPatientsAdultsSubspecialists
2019
Increased Length of Stay Associated With Antibiotic Use in Older Adults With Advanced Cancer Transitioned to Comfort Measures
Datta R, Zhu M, Han L, Allore H, Quagliarello V, Juthani-Mehta M. Increased Length of Stay Associated With Antibiotic Use in Older Adults With Advanced Cancer Transitioned to Comfort Measures. American Journal Of Hospice And Palliative Medicine® 2019, 37: 27-33. PMID: 31185722, PMCID: PMC6868290, DOI: 10.1177/1049909119855617.Peer-Reviewed Original ResearchConceptsAdvanced cancerAntibiotic useComfort measuresPoisson regression modelsInfection diagnosisIntensive care unit admissionMultivariable Poisson regression modelsCare unit admissionCohort of patientsUrinary tract infectionGoal-concordant careUnit admissionEnd of lifeHospital lengthOlder patientsTract infectionsLonger LOSMedian ageRegression modelsStay AssociatedAntibiotic exposureLiquid tumorsPatientsCancerCancer typesAntimicrobial therapy for asymptomatic bacteriuria or candiduria in advanced cancer patients transitioning to comfort measures
Datta R, Wang T, Zhu M, Dembry LM, Han L, Allore H, Quagliarello V, Juthani-Mehta M. Antimicrobial therapy for asymptomatic bacteriuria or candiduria in advanced cancer patients transitioning to comfort measures. Infection Control And Hospital Epidemiology 2019, 40: 470-472. PMID: 30821230, PMCID: PMC6482377, DOI: 10.1017/ice.2019.22.Peer-Reviewed Original ResearchConceptsUrinary tract infectionIncidence rate ratiosAdvanced cancer patientsAsymptomatic bacteriuriaCancer patientsAntimicrobial therapySymptomatic urinary tract infectionPotential urinary tract infectionTract infectionsInappropriate therapyAntimicrobial daysComfort measuresBacteriuriaCandiduriaCFU/mLPatientsTherapyRate ratioMLInfection
2018
Long-Acting Lipoglycopeptides for Gram-Positive Bacteremia at the End of Life to Facilitate Hospice Care: A Report of 3 Cases
Datta R, McManus D, Topal J, Juthani-Mehta M. Long-Acting Lipoglycopeptides for Gram-Positive Bacteremia at the End of Life to Facilitate Hospice Care: A Report of 3 Cases. Open Forum Infectious Diseases 2018, 5: ofx277. PMID: 29399598, PMCID: PMC5788065, DOI: 10.1093/ofid/ofx277.Peer-Reviewed Original Research
2017
Burden and Management of Multidrug-Resistant Organisms in Palliative Care
Datta R, Juthani-Mehta M. Burden and Management of Multidrug-Resistant Organisms in Palliative Care. Palliative Care And Social Practice 2017, 10: 1178224217749233. PMID: 29317826, PMCID: PMC5753884, DOI: 10.1177/1178224217749233.Peer-Reviewed Original ResearchMultidrug-resistant organismsPalliative careTerminal illnessGoals of palliationPalliative care patientsPalliative care settingAvailable treatment optionsInfection prevention measuresQuality of lifeCommon complicationContact precautionsMetastatic diseaseCare patientsPatient isolationTreatment optionsSymptom assessmentCare discussionsAntimicrobial therapyCommon signsCare settingsCognitive impairmentPsychological burdenPatientsInfectionAdverse effects
2015
Quantifying the Exposure to Antibiotic-Resistant Pathogens Among Patients Discharged From a Single Hospital Across All California Healthcare Facilities
Datta R, Brown S, Nguyen VQ, Cao C, Billimek J, Avery T, Lee BY, Huang SS. Quantifying the Exposure to Antibiotic-Resistant Pathogens Among Patients Discharged From a Single Hospital Across All California Healthcare Facilities. Infection Control And Hospital Epidemiology 2015, 36: 1275-1282. PMID: 26387690, DOI: 10.1017/ice.2015.181.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsCaliforniaCarrier StateClostridiumCross InfectionDrug Resistance, BacterialFemaleHospitalsHumansKlebsiella pneumoniaeLength of StayMaleMethicillin-Resistant Staphylococcus aureusMiddle AgedNursing HomesPatient DischargePatient ReadmissionRetrospective StudiesVancomycin-Resistant EnterococciYoung AdultConceptsMethicillin-resistant Staphylococcus aureusClostridium difficile infectionVancomycin-resistant enterococciNursing homesAntibiotic-resistant pathogensDays of dischargeHealthcare facilitiesLength of stayExtended-spectrum β-lactamaseYear of dischargeMultiple cohort studiesTime-dependent exposureESBL carriersMore readmissionsCDI patientsHospital readmissionDifficile infectionSingle hospitalReadmissionHospitalPatientsKlebsiella pneumoniaeΒ-lactamaseStaphylococcus aureusNoncarriers
2013
High Nasal Burden of Methicillin-Resistant Staphylococcus aureus Increases Risk of Invasive Disease
Datta R, Shah A, Huang SS, Cui E, Nguyen V, Welbourne SJ, Quan KA, Thrupp L. High Nasal Burden of Methicillin-Resistant Staphylococcus aureus Increases Risk of Invasive Disease. Journal Of Clinical Microbiology 2013, 52: 312-314. PMID: 24153126, PMCID: PMC3911445, DOI: 10.1128/jcm.01606-13.Peer-Reviewed Original ResearchDiscord among Performance Measures for Central Line—Associated Bloodstream Infection
Tehrani DM, Russell D, Brown J, Boynton-Delahanty K, Quan K, Gibbs L, Braddock G, Zaroda T, Koopman M, Thompson D, Nichols A, Cui E, Liu C, Cohen S, Rubin Z, Pegues D, Torriani F, Datta R, Huang SS. Discord among Performance Measures for Central Line—Associated Bloodstream Infection. Infection Control And Hospital Epidemiology 2013, 34: 176-183. PMID: 23295564, DOI: 10.1086/669090.Peer-Reviewed Original ResearchMeSH KeywordsAcademic Medical CentersAdolescentAdultAgedAged, 80 and overBacteremiaCaliforniaCatheter-Related InfectionsCenters for Medicare and Medicaid Services, U.S.Clinical CodingCross InfectionFemaleHumansInsurance Claim ReviewMaleMandatory ProgramsMedical AuditMiddle AgedRetrospective StudiesUnited StatesYoung AdultConceptsCentral line-associated bloodstream infectionsChart reviewConsecutive patientsBloodstream infectionsNHSN criteriaClaims codesCommon reasonNational Healthcare Safety Network criteriaCentral Line–Associated Bloodstream InfectionsMulticenter retrospective cohort studyLine–Associated Bloodstream InfectionsLine-associated bloodstream infectionsRetrospective cohort studyMedical record reviewCLABSI eventsCLABSI reportingCohort studyRecord reviewPrevention criteriaClaims dataNetwork criteriaPhysician documentationClaims cohortPatientsDisease control
2010
Risk of Postdischarge Infection with Vancomycin-Resistant Enterococcus after Initial Infection or Colonization
Datta R, Huang SS. Risk of Postdischarge Infection with Vancomycin-Resistant Enterococcus after Initial Infection or Colonization. Infection Control And Hospital Epidemiology 2010, 31: 1290-1293. PMID: 20979493, PMCID: PMC3075426, DOI: 10.1086/657332.Peer-Reviewed Original Research
2008
Strain-Relatedness of Methicillin- Resistant Staphylococcus aureus Isolates Recovered from Patients with Repeated Infection
Huang SS, Diekema DJ, Warren DK, Zuccotti G, Winokur PL, Tendolkar S, Boyken L, Datta R, Jones RM, Ward MA, Aubrey T, Onderdonk AB, Garcia C, Platt R. Strain-Relatedness of Methicillin- Resistant Staphylococcus aureus Isolates Recovered from Patients with Repeated Infection. Clinical Infectious Diseases 2008, 46: 1241-1247. PMID: 18444862, PMCID: PMC2723744, DOI: 10.1086/529381.Peer-Reviewed Original ResearchConceptsMethicillin-Resistant Staphylococcus aureus IsolatesMethicillin-resistant Staphylococcus aureus (MRSA) detectionStaphylococcus aureus isolatesMRSA infectionRepeated infectionsInvasive diseaseLate infectionAureus isolatesInfectionSame strainInitial detectionMost casesStaphylococcus aureus detectionIsolatesPatientsDiseaseWeeks
2006
Risk of Acquiring Antibiotic-Resistant Bacteria From Prior Room Occupants
Huang SS, Datta R, Platt R. Risk of Acquiring Antibiotic-Resistant Bacteria From Prior Room Occupants. JAMA Internal Medicine 2006, 166: 1945-1951. PMID: 17030826, DOI: 10.1001/archinte.166.18.1945.Peer-Reviewed Original ResearchMeSH KeywordsBostonCarrier StateCohort StudiesCross InfectionEnterococcusFemaleGram-Positive Bacterial InfectionsHospitalizationHumansIntensive Care UnitsMaleMethicillin ResistanceMiddle AgedOdds RatioPatients' RoomsRetrospective StudiesRiskStaphylococcal InfectionsStaphylococcus aureusVancomycin ResistanceConceptsMethicillin-resistant Staphylococcus aureusPrior room occupantsVancomycin-resistant enterococciMRSA-positive patientsVRE-positive patientsRetrospective cohort studyIntensive care unitPopulation attributable riskCare of patientsRisk of transmissionRoutes of transmissionOdds of acquisitionMRSA casesVRE casesCohort studyRoutine admissionCare unitWeekly screeningExcess riskAttributable riskRelative oddsPatientsRoom occupantsAntibiotic-resistant bacteriaAdmission